MyFinsight
Home
Blog
About
Marketable securities
$103,417K
(7271.13%↑ Y/Y)
Cash and cash
equivalents
$57,073K
(-19.92%↓ Y/Y)
Prepaid expenses and
other current assets
$5,944K
(5.52%↑ Y/Y)
Restricted cash
$4,195K
(0.00%↑ Y/Y)
Property and equipment,
at cost
$84,546K
(-1.35%↓ Y/Y)
Total current assets
$170,629K
(106.82%↑ Y/Y)
Goodwill
$140,627K
(0.00%↑ Y/Y)
Intangible asset
$59,195K
(0.00%↑ Y/Y)
Operating lease
right-of-use assets
$35,355K
(-17.82%↓ Y/Y)
Property and equipment,
net
$25,164K
(-23.93%↓ Y/Y)
Other non-current
assets
$552K
(-82.85%↓ Y/Y)
Less accumulated
depreciation
$59,382K
(12.85%↑ Y/Y)
Total assets
$431,522K
(19.32%↑ Y/Y)
Total liabilities and
stockholders' equity
$431,522K
(19.32%↑ Y/Y)
Total liabilities
$276,954K
(15.84%↑ Y/Y)
Total stockholders'
equity
$154,568K
(26.12%↑ Y/Y)
Accumulated deficit
-$1,959,861K
(-12.12%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$66K
Total current
liabilities
$123,752K
(270.03%↑ Y/Y)
Contingent consideration,
net of current...
$60,013K
(-48.76%↓ Y/Y)
Operating lease
liabilities, net of current...
$59,232K
(-17.34%↓ Y/Y)
Success payment
liabilities
$24,477K
(184.25%↑ Y/Y)
Other non-current
liabilities
$9,480K
(15.02%↑ Y/Y)
Additional paid-in capital
$2,114,465K
(13.04%↑ Y/Y)
Common stock, 0.0001
par value 750,000...
$30K
(30.43%↑ Y/Y)
Contingent consideration
$90,812K
(-22.47%↓ Y/Y)
Operating lease
liabilities
$14,507K
(4.88%↑ Y/Y)
Accrued compensation
$8,842K
(-6.05%↓ Y/Y)
Accrued expenses and
other current...
$8,232K
(3.80%↑ Y/Y)
Accounts payable
$1,359K
(-40.13%↓ Y/Y)
Back
Back
Balance Sheet
Sana Biotechnology, Inc. (SANA)
Sana Biotechnology, Inc. (SANA)
source: myfinsight.com